Inferra AI / Company / OGI
OrganiGram Holdings
OGI · Health Care
Last earnings Aug 11, 2026
Key results
Revenuequarter
$105,782
REVENUE For Q3 Fiscal 2026, the Company reported $105,782 in net revenue.
SEC original ↗OrganiGram Holdings — Earnings release (6-K exhibit)EX-99Aug 11, 2026
Of this amount, $61,817 (58%) was attributable to recreational cannabis sales, $39,033 (37%) to medical sales, which are mostly international, and $4,932 (5%) to wholesale, and other revenues.
SEC original ↗OrganiGram Holdings — Earnings release (6-K exhibit)EX-99Aug 11, 2026
Net revenuequarter
49%
Net revenue for Q3 Fiscal 2026 increased by 49%, or $34,990, from $70,792 in Q3 Fiscal 2025.
SEC original ↗OrganiGram Holdings — Earnings release (6-K exhibit)EX-99Aug 11, 2026
COST OF SALES Cost of sales for Q3 Fiscal 2026 increased to $66,980 compared to $48,369 in Q3 Fiscal 2025, primarily due to the contribution of Sanity Group and the associated increase in net revenue of 49% in Q3 Fiscal 2026 compared to Q3 Fiscal 2025.
SEC original ↗OrganiGram Holdings — Earnings release (6-K exhibit)EX-99Aug 11, 2026
Gross marginquarter
$38,802,
GROSS MARGIN BEFORE FAIR VALUE ADJUSTMENTS AND ADJUSTED GROSS MARGIN The Company realized gross margin before fair value adjustments for Q3 Fiscal 2026 of $38,802, or 37% as a percentage of net revenue, compared to $22,423, or 32%, in Q3 Fiscal 2025 .
SEC original ↗OrganiGram Holdings — Earnings release (6-K exhibit)EX-99Aug 11, 2026
Adjusted gross marginquarter
$39,065,
Adjusted gross margin 4 for Q3 Fiscal 2026 was $39,065, or 37% as a percentage of net revenue, compared to $24,226, or 34%, in Q3 Fiscal 2025.
SEC original ↗OrganiGram Holdings — Earnings release (6-K exhibit)EX-99Aug 11, 2026
As a percentage of net revenue, sales and marketing expenses decreased to 11% in Q3 Fiscal 2026 compared to 12% in Q3 Fiscal 2025.
SEC original ↗OrganiGram Holdings — Earnings release (6-K exhibit)EX-99Aug 11, 2026
Operating incomequarter
$1,099
OTHER NON-OPERATING (INCOME) EXPENSES Other non-operating income of $1,099 in Q3 Fiscal 2026, compares to other non-operating expenses of $2,107 in Q3 Fiscal 2025, an improvement of $3,206.
SEC original ↗OrganiGram Holdings — Earnings release (6-K exhibit)EX-99Aug 11, 2026
AI analysis
Q2 2026 · reported Aug 11, 2026
Based on: Earnings release (6-K exhibit) + parent 6-K — transcript not held
Headline figures
| Metric | Q2 2026 | Prior qtr | Year ago |
|---|---|---|---|
| Revenue | $105,782 | — | — |
| Net revenue | 49% | — | — |
| Gross margin | $38,802, | — | — |
| Adjusted gross margin | $39,065, | — | — |
| Operating income | $1,099 | — | — |
Guidance · company-stated
Direction: Raised
“OUTLOOK Market Size Industry Trends The Company maintains a positive outlook on the cannabis industry, both in Canada and internationally.”
“However, the Company is updating its Fiscal 2026 free cash flow outlook to reflect higher working capital requirements associated with its increased scale and business activity and now expects modest negative free cash flow for the full fiscal year.”
Classified from the release's primary full-year outlook statement.
Margin
Capital allocation
This increase was partially offset by a $3,012 recovery of a previously recorded bad debt provision.
In connection with the closing of the acquisition, the Company also closed its private placement financing with a wholly-owned subsidiary of BAT, for total gross proceeds of 40.3 million (equal to C$65.2 million), and its senior secured credit facilities of up to C$60 million with ATB Financial (the Credit Facility ).
Event summary
OrganiGram Holdings Q2 2026 — REVENUE For Q3 Fiscal 2026, the Company reported $105,782 in net revenue.
Based on: Earnings release (6-K exhibit) + parent 6-K — transcript not held
Guidance & outlook
Direction: Raised
Company outlook — Reiterated (“maintains”)
“OUTLOOK Market Size Industry Trends The Company maintains a positive outlook on the cannabis industry, both in Canada and internationally.”
Company outlook — Raised (“increased”)
“However, the Company is updating its Fiscal 2026 free cash flow outlook to reflect higher working capital requirements associated with its increased scale and business activity and now expects modest negative free cash flow for the full fiscal year.”
Classified from the release's primary full-year outlook statement.
Capital allocation
This increase was partially offset by a $3,012 recovery of a previously recorded bad debt provision.
SEC original ↗OrganiGram Holdings — Earnings release (6-K exhibit)EX-99Aug 11, 2026
In connection with the closing of the acquisition, the Company also closed its private placement financing with a wholly-owned subsidiary of BAT, for total gross proceeds of 40.3 million (equal to C$65.2 million), and its senior secured credit facilities of up to C$60 million with ATB Financial (the Credit Facility ).
SEC original ↗OrganiGram Holdings — Earnings release (6-K exhibit)EX-99Aug 11, 2026
The increased expenses mainly relate to the inclusion of Sanity Group's general and administrative expenses, higher depreciation and amortization resulting from the acquisitions of Motif and Sanity, increased professional fees, and a credit loss due to a customer insolvency, substantially offset by a $3,012 recovery of a previously recorded bad debt provision.
SEC original ↗OrganiGram Holdings — Earnings release (6-K exhibit)EX-99Aug 11, 2026
During Q3 Fiscal 2026, the Company completed the acquisition of Sanity Group, funded through proceeds from the BAT private placement together with a $20 million non-revolving term facility (the Term Facility ) drawn under the Credit Facility entered into to support liquidity and financial flexibility.
SEC original ↗OrganiGram Holdings — Earnings release (6-K exhibit)EX-99Aug 11, 2026
The Credit Facility consists of (i) the Term Facility, used to partially fund the acquisition of Sanity Group (ii) a $30 million revolving credit facility and (iii) a $10 million operating facility for general corporate purposes.
SEC original ↗OrganiGram Holdings — Earnings release (6-K exhibit)EX-99Aug 11, 2026
Following the acquisition of Sanity Group and establishment of the Credit Facility, management believes the Company maintains sufficient liquidity and financial flexibility to fund operations, meet working capital requirements, and support planned growth initiatives over the medium term.
SEC original ↗OrganiGram Holdings — Earnings release (6-K exhibit)EX-99Aug 11, 2026
Strategy & priorities
Lac-Sup rieur Facility (Hash Concentrates and Premium Flower) The Lac-Sup rieur Facility is a greenhouse facility which provides a strategic footprint in Quebec, spans 33,000 square feet of space.
SEC original ↗OrganiGram Holdings — Earnings release (6-K exhibit)EX-99Aug 11, 2026
STRATEGY Our corporate strategy is to leverage our strengths in innovation, consumer focus, efficiency, and market expansion to profitably drive global growth and shareholder value.
SEC original ↗OrganiGram Holdings — Earnings release (6-K exhibit)EX-99Aug 11, 2026
Efficiency We continue to implement initiatives to reduce costs and improve scalability and margins through ongoing investments in facility automation, cultivation practices (including seed-based cultivation), and logistics efficiency, particularly at our London Facility.
SEC original ↗OrganiGram Holdings — Earnings release (6-K exhibit)EX-99Aug 11, 2026
Market Expansion Organigram is committed to expanding its market presence through both organic growth and strategic diversification.
SEC original ↗OrganiGram Holdings — Earnings release (6-K exhibit)EX-99Aug 11, 2026
Our key initiatives have included Domestic expansion acquisitions of cannabis cultivation and production facilities across Ontario, Qu bec, and Manitoba, enabling participation in all major Canadian product categories.
SEC original ↗OrganiGram Holdings — Earnings release (6-K exhibit)EX-99Aug 11, 2026
Risks & headwinds
Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual events to differ materially from current expectations.
SEC original ↗OrganiGram Holdings — Earnings release (6-K exhibit)EX-99Aug 11, 2026
Forward looking information is subject to risks and uncertainties that are addressed in the Risk Factors section of the MD A dated August 11, 2026 and there can be no assurance whatsoever that these events will occur.
SEC original ↗OrganiGram Holdings — Earnings release (6-K exhibit)EX-99Aug 11, 2026
Although we believe these sources to be generally reliable, market and industry data is inherently imprecise, subject to interpretation and cannot be verified with complete certainty due to limits on the availability and reliability of raw data, the voluntary nature of the data gathering process, and other limitations and uncertainties inherent in any statistical survey or data collection process.
SEC original ↗OrganiGram Holdings — Earnings release (6-K exhibit)EX-99Aug 11, 2026
Competitors
Competitors & peers
Same GICS sector — classification peers, not declared competitors
Filings
34 documents- Q3 2026
- 6-KOGI
Oct 15, 2026
- EX-99OGI
Oct 15, 2026
- Q2 2026
- 6-KOGI
Sep 30, 2026
- EX-99OGI
Sep 30, 2026
- 6-KOGI
- EX-99OGI
Sep 3, 2026
- 6-KOGI
- EX-99OGI
Sep 1, 2026
- EX-99OGI
Sep 1, 2026
- EX-99OGI
Sep 1, 2026
- 6-KOGI
Aug 20, 2026
- EX-99OGI
Aug 20, 2026
- 6-KOGI
- EX-99OGI
Aug 11, 2026
- EX-99OGI
Aug 11, 2026
- 6-KOGI
- 6-KOGI
Jul 20, 2026
- Q1 2026
- 6-KOGI
- 6-KOGI
- 6-KOGI
Apr 16, 2026
- Q4 2025
- 6-KOGI
Mar 31, 2026
- 6-KOGI
Mar 23, 2026
- 6-KOGI
Mar 11, 2026
- 6-KOGI
- 6-KOGI
- 6-KOGI
- 6-KOGI
Feb 24, 2026
- 6-KOGI
- 6-KOGI
- 6-KOGI
Feb 19, 2026
- 6-KOGI
Feb 18, 2026
- 6-KOGI
- 6-KOGI
- 6-KOGI
Earnings releases
3 documentsPresentations
0 documentsNo presentations for OrganiGram Holdings are held in this edition of the library.
Transcripts
0 documentsNo transcripts for OrganiGram Holdings are held in this edition of the library.
Mentioned by
1 companyOther tracked companies whose held documents mention OrganiGram Holdings by name or ticker. A mention is counted once per document, from the document text the library holds.
British American Tobacco (BTI)
“… Group (continued) Organigram Global Inc. ( Organigram ) In February 2026, Organigram announced the acquisition of Sanity Group GmbH (Sanity). As previously disclosed, prior to th”
See also the earnings calendar for every tracked company’s next earnings date.